Search

everythinglearnresearchcommunity

for

Search:↓

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Microneedling with platelet-rich plasma can improve different types of hair loss.

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Alopecia areata affects quality of life more in adolescents than adults.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

COVID-19 may trigger alopecia areata, but more research is needed.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Nail changes in alopecia areata are common and may indicate severity and genetic risk.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Ayurvedic treatment significantly improved hair loss in a 17-year-old male.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Some breast cancer chemotherapy can cause permanent hair loss.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.